APA (7th ed.) Citation

Dai, Y., Wu, F., Ni, S., Hu, X., Han, Y., Jiao, Y., . . . Lu, L. (2025). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of HSK39297 in Chinese Healthy Subjects: A Phase 1 Clinical Trial. Clinical and translational science, 18(7), e70281. https://doi.org/10.1111/cts.70281

Chicago Style (17th ed.) Citation

Dai, Yuyang, et al. "Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of HSK39297 in Chinese Healthy Subjects: A Phase 1 Clinical Trial." Clinical and Translational Science 18, no. 7 (2025): e70281. https://doi.org/10.1111/cts.70281.

MLA (9th ed.) Citation

Dai, Yuyang, et al. "Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of HSK39297 in Chinese Healthy Subjects: A Phase 1 Clinical Trial." Clinical and Translational Science, vol. 18, no. 7, 2025, p. e70281, https://doi.org/10.1111/cts.70281.